Meanwhile, the BSE Sensex was down 132.49 points, or 0.71%, to 18,398.79.
On BSE, 18,491 shares were traded in the counter as against average daily volume of 14,674 shares over the past one quarter.
The stock hit a high of Rs 148.80 and a low of Rs 139.50 so far during the day. The stock had hit a record high of Rs 399.95 on 10 November 2010 and a 52-week low of Rs 134.15 on 17 March 2011.
The small-cap stock had underperformed the market over the past one month till 13 May 2011, declining 19.23% compared with the Sensex's 5.92% fall. The stock had also underperformed the market in past one quarter, falling 32.47% as against Sensex's return of 4.53%.
The company has an equity capital of Rs 25.87 crore. Face value per share is Rs 10.
Parenteral Drugs (India)'s net sales plunged 48.7% to Rs 57.26 crore in Q4 March 2011 over Q4 March 2010. The company announced the results on Saturday, 14 March 2011.
The company's net profit tumbled 78.6% to Rs 6.52 crore on 20.6% rise in net sales to Rs 499.73 crore in the year ended March 2011 over the year ended March 2010.